Neuronetics (STIM) Gross Profit Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.52% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.76% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 4.41% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 12.59% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.74% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.30% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 27.39% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -1.74% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 8.72% |
| 10 | Neuronetics | 3.26 Mn | -6.42 Mn | 16.15 Mn | 2.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.64% |
| Dec 31, 2025 | 45.73% |
| Sep 30, 2025 | 22.19% |
| Jun 30, 2025 | 45.81% |
| Mar 31, 2025 | 20.25% |
| Dec 31, 2024 | -5.57% |
| Sep 30, 2024 | 19.02% |
| Jun 30, 2024 | -4.66% |
| Mar 31, 2024 | 14.85% |
| Dec 31, 2023 | 14.22% |
| Sep 30, 2023 | -9.00% |
| Jun 30, 2023 | 3.94% |
| Mar 31, 2023 | 6.54% |
| Dec 31, 2022 | 20.24% |
| Sep 30, 2022 | 21.33% |
| Jun 30, 2022 | 7.31% |
| Mar 31, 2022 | 6.25% |
| Dec 31, 2021 | -2.81% |
| Sep 30, 2021 | 8.82% |
| Jun 30, 2021 | 54.39% |
| Mar 31, 2021 | 16.18% |
| Dec 31, 2020 | -10.06% |
| Sep 30, 2020 | -17.08% |
| Jun 30, 2020 | -40.18% |
| Mar 31, 2020 | -12.66% |
| Dec 31, 2019 | 10.17% |
| Sep 30, 2019 | 10.32% |
| Jun 30, 2019 | 23.92% |
| Mar 31, 2019 | 28.93% |
| Dec 31, 2018 | 30.30% |
| Sep 30, 2018 | 36.26% |
| Jun 30, 2018 | 28.18% |
| Mar 31, 2018 | 28.51% |